Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 5
2004 4
2005 9
2006 4
2007 16
2008 12
2009 13
2010 19
2011 21
2012 18
2013 26
2014 30
2015 30
2016 21
2017 16
2018 15
2019 21
2020 23
2021 26
2022 18
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

299 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for giuseppe di lorenzo
Search for Giuseppe De Lorenzo instead (2 results)
Biomarkers in localized prostate cancer.
Ferro M, Buonerba C, Terracciano D, Lucarelli G, Cosimato V, Bottero D, Deliu VM, Ditonno P, Perdonà S, Autorino R, Coman I, De Placido S, Di Lorenzo G, De Cobelli O. Ferro M, et al. Among authors: di lorenzo g. Future Oncol. 2016 Feb;12(3):399-411. doi: 10.2217/fon.15.318. Epub 2016 Jan 15. Future Oncol. 2016. PMID: 26768791 Free PMC article. Review.
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis.
Wu Z, Chen Q, Qu L, Li M, Wang L, Mir MC, Carbonara U, Pandolfo SD, Black PC, Paul AK, Di Lorenzo G, Porpiglia F, Mari A, Necchi A, Rouprêt M, Psutka SP, Autorino R. Wu Z, et al. Among authors: di lorenzo g. Eur Urol. 2022 Apr;81(4):414-425. doi: 10.1016/j.eururo.2022.01.028. Epub 2022 Jan 31. Eur Urol. 2022. PMID: 35101302 Free article. Review.
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings.
Ferro M, Lucarelli G, Crocetto F, Dolce P, Verde A, La Civita E, Zappavigna S, de Cobelli O, Di Lorenzo G, Facchini BA, Scafuri L, Onofrio L, Porreca A, Busetto GM, Sonpavde G, Caraglia M, Klain M, Terracciano D, De Placido S, Buonerba C. Ferro M, et al. Among authors: di lorenzo g. Crit Rev Oncol Hematol. 2021 Jan;157:103198. doi: 10.1016/j.critrevonc.2020.103198. Epub 2020 Dec 13. Crit Rev Oncol Hematol. 2021. PMID: 33316417
Immune checkpoint inhibitors in penile cancer.
Buonerba C, Scafuri L, Costabile F, D'Ambrosio B, Gatani S, Verolino P, Trolio RD, Cosimato V, Verde A, Lorenzo GD. Buonerba C, et al. Among authors: lorenzo gd. Future Sci OA. 2021 May 21;7(7):FSO714. doi: 10.2144/fsoa-2021-0044. eCollection 2021 Aug. Future Sci OA. 2021. PMID: 34258024 Free PMC article. No abstract available.
Immunotherapy for penile cancer.
Buonerba C, Pagliuca M, Vitrone FM, Ascione I, Elefante I, Riccio V, Romano F, De Placido S, Di Lorenzo G. Buonerba C, et al. Among authors: di lorenzo g. Future Sci OA. 2017 May 2;3(3):FSO195. doi: 10.4155/fsoa-2017-0031. eCollection 2017 Aug. Future Sci OA. 2017. PMID: 28883996 Free PMC article. No abstract available.
The role of immunotherapy in oncology.
Riccio V, Carrano S, Buonerba C, Di Lorenzo G. Riccio V, et al. Among authors: di lorenzo g. Future Oncol. 2015;11(21):2861-4. doi: 10.2217/fon.15.237. Epub 2015 Sep 25. Future Oncol. 2015. PMID: 26404049 No abstract available.
299 results